Clinical Trial Update: RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study [Phase 2]

View source ↗

Summary

An update on a Phase 2 pilot trial (RATNO) investigating nitric oxide to reduce antibiotic tolerance in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• RATNO

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED